Navigation Links
New crops needed for new climate
Date:6/28/2009

Global food security in a changing climate depends on the nutritional value and yield of staple food crops. Researchers at Monash University in Victoria, Australia have found an increase in toxic compounds, a decrease in protein content and a decreased yield in plants grown under high CO2 and drought conditions.

The research, to be presented by Dr Ros Gleadow on 29 June 2009 at the Society for Experimental Biology Annual Meeting in Glasgow, has shown that the concentration of cyanogenic glycosides, which break down to release toxic hydrogen cyanide, increased in plants in elevated CO2. This was compounded by the fact that protein content decreased, making the plants overall more toxic as the ability of herbivores to break down cyanide depends largely on the ingestion of sufficient quantities of protein.

Data have also shown that cassava, a staple food crop in tropical and subtropical regions due to its tolerance of arid conditions, may experience yield reductions in high CO2. Combined with an increase in cyanogenic glycosides, this has major implications for the types of crops that can be grown in the future if CO2 levels continue to rise: "We need to be preparing for the predicted reduction in nutritional value of many plants in the coming century by developing and growing different cultivars which, for cassava in particular, may not be easy' says Dr Gleadow.


'/>"/>

Contact: Tess Livermore
TXL442@bham.ac.uk
44-776-699-5076
Society for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. MIT: Human-generated ozone will damage crops
2. Iowa Staters talk biofuels, healthy oils and pharma crops at AAAS meeting
3. What farmers think about GM crops
4. Gene that controls ozone resistance of plants could lead to drought-resistant crops
5. Are organic crops as productive as conventional?
6. Herbicide-tolerant crops can improve water quality
7. Energy crops take a roasting
8. Rising energy, food prices major threats to wetlands as farmers eye new areas for crops
9. MSU to create genomic clearinghouse for biofuel crops
10. Shade trees can protect coffee crops
11. How to build crops that can beat aluminums toxic effects

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wa - The only swine vaccine available for the H1N1...ected with the virus. The vaccination marks the fi...gnosed with the pandemic flu., Iowa State Univer...eveloped the vaccine this summer and has been ship...Kansas and Illinois for several weeks., The late...
(Date:11/23/2009)... Ill. Two new studies reveal in unprecedented det...s to assemble new proteins and guide them toward t...used molecular dynamics flexible fitting (MDFF) to...prominent molecular partners. , The first study...ces , concerns the intimate signaling between the ...
(Date:11/23/2009)...al Institute of General Medical Sciences (NIGMS), ...s investing $42.3 million for grants in scientific..." NIH developed the GO grant program to stimulate ...ovided by the American Recovery and Reinvestment A...s that promise to have a significant impact on a f...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3SyntheMed Receives US Patent on Novel Polymer Technology 13286 1SyntheMed Receives US Patent on Novel Polymer Technology 13286 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 1Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 3TriReme Medical Inc Receives CE Marking for Glider 28TM 29 PTCA Dilatation Catheter 53214 1TriReme Medical Inc Receives CE Marking for Glider 28TM 29 PTCA Dilatation Catheter 53214 2
...LA Research led by David Worthylake, PhD, Assista... at LSU Health Sciences Center New Orleans, may he...pound to prevent the spread of cancer. The researc...he Journal of Biological Chemistry . , During th...disease, cancer cells acquire the ability to detac...
...0 years it has become commonplace to think of Eart...tain equilibrium so that life might continue and f...ncient Greek goddess of Earth, even put forth the ...ganism, with its complex systems finely tuned to c...But actually it is the Gaia view that is out of ki...
...ms to forget things, will she end up demented? The...ms that may signal which 70-year-olds risk develop...t the Sahlgrenska Academy at the University of Got...y used to predict which elderly individuals risk d... The thesis shows that memory loss is the only fac...
Other Biology News:LSUHSC research describes function of key protein in cancer spread 2New book suggests Earth perhaps not such a benevolent mother after all 2New book suggests Earth perhaps not such a benevolent mother after all 3Early identification of dementia increasingly difficult 2
(Date:11/23/2009)...tive new study, a University of Utah scientist arg...r cause of global warming cannot be stabilized un...ds the equivalent of one new nuclear power plant e...e any substantial near-term departure from recentl... rates," says the new paper by Tim Garrett, an ass...
(Date:11/23/2009)...FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI )t...09astheex-dividenddateforits$200millionspecialdivi...ansactioncompletedonNovember2,2009.Thedividendwill...therecorddate,December1,2009.NASDAQhassettheapprox...ommonstockforpurposesoftheex-dividenddateonNovembe...
(Date:11/23/2009)...gnC or p.(IDC)announcedtodaythatDr.BruceL.A.Carter...ssfultrackrec or dinbiotechnologyexecutivemanageme...tics,inSeattle,WAandChiefScientificOfficeratNovoN ...ww.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...cercommented,"IamdelightedtowelcomeDr.BruceCartera...
(Date:11/23/2009)...--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),aspec...opingandcommercializingsignificantproductsprimaril...thatCraigA.Collard,PresidentandChiefExecutiveOffic...alPiperJaffrayHealthCareConferenceat3:30PMETonWedn...rkCity. ,, AliveaudioandarchivedwebcastofCorner...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2
...Pharma, Inc. (Nasdaq:,GORX) announced today that i...ts of its third fiscal quarter ended December 31, ...ET) with CEO, Mihir Taneja and VP/CFO,Carol Dore-F...erence call,by utilizing the following URL, http:/...?key=PVYY97BW8 thus,avoiding operator assistance ...
... Schering-Plough,Corporation (NYSE: SGP ) today ...on (FDA) has accepted the Peg-IFN (peginterferon a... (sBLA) for review and has,granted Priority Review...h,Stage III melanoma. Schering-Plough submitted it... The Priority Review designation is intended to ex...
...help doctors and clinicians identify best t...ease, BIRMINGHAM, Ala., Jan. 31 Clinical trial r...ation point to the need for more,detailed choleste...nd other,lipids. That,s according to Atherotech, a...xpanded cholesterol test called the VAP (Vertical ...
Other Biology Technology:GeoPharma Announces Third Quarter Conference Call 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3
Goat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from Abcam
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119] NON-neutralizing Polyclonal Antibody, Unconjugated from Cell Sciences
Anti-AANAT Antibody, Unconjugated from CHEMICON
Biology Products: